TYMS and lung carcinoma: The data also showed that tumor histology was able to predict the sensitivity of pemetrexed therapy in lung cancer, and that expression of TS mRNA and TS protein differed between squamous cell lung cancer or NSCLC and lung adenocarcinoma [5].